No Data
GSK Says Trial of Itch Treatment Linerixibat Meets Primary Endpoint
Linerixibat Shows Positive Phase III Results in Cholestatic Pruritus (Relentless Itch) in Primary Biliary Cholangitis (PBC)
Express News | Us CDC Says Since April Confirmed Avian Influenza A(H5) Virus Infections In 52 People In US; Aware Of Human Case Of H5N1 Bird Flu Reported In Canada & Is In Communication With Public Health Agency Of Canada
Global Companies With at Least 50% U.S. Revenue Exposure as Trump Eyes Tariffs: BofA
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
GSK Cut to Hold From Buy by Deutsche Bank
